HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip E Castle Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

11/2023A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.
10/2023Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.
1/2023An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
1/2023A low-cost, paper-based hybrid capture assay to detect high-risk HPV DNA for cervical cancer screening in low-resource settings.
1/2022Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda.
1/2021Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening.
1/2020The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.
1/2020Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
1/2019Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
1/2019Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip E Castle Research Topics

Disease

55Neoplasms (Cancer)
05/2024 - 09/2002
51Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2023 - 09/2002
28Uterine Cervical Dysplasia
01/2024 - 09/2002
19Papillomavirus Infections
01/2020 - 01/2002
17Infections
01/2022 - 01/2002
13Atypical Squamous Cells of the Cervix
01/2022 - 01/2002
10Squamous Intraepithelial Lesions
10/2020 - 08/2004
4Anus Neoplasms (Anal Cancer)
10/2022 - 11/2012
3Carcinogenesis
09/2017 - 06/2008
3Inflammation (Inflammations)
07/2004 - 01/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2015
2Vaginal Neoplasms (Cancer, Vaginal)
04/2016 - 01/2016
2Coinfection
02/2009 - 07/2004
2Carcinoma (Carcinomatosis)
10/2003 - 11/2002
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
07/2003 - 07/2002
1Opportunistic Infections (Opportunistic Infection)
01/2024
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Disease Progression
11/2018
1Necrosis
07/2017
1Adenocarcinoma in Situ
04/2013
1Endometrial Neoplasms (Endometrial Cancer)
02/2010
1Cough
10/2007
1Reproductive Tract Infections
01/2003
1Human Influenza (Influenza)
11/2002
1Tetanus
11/2002
1Herpes Zoster
04/2002

Drug/Important Bio-Agent (IBA)

47DNA (Deoxyribonucleic Acid)IBA
11/2023 - 09/2002
22Biomarkers (Surrogate Marker)IBA
05/2024 - 11/2005
15VaccinesIBA
03/2024 - 07/2003
11Papillomavirus Vaccines (HPV Vaccines)IBA
01/2022 - 08/2009
6AntibodiesIBA
11/2017 - 03/2002
5Coloring Agents (Dyes)IBA
10/2022 - 12/2014
5Acetic Acid (Vinegar)FDA LinkGeneric
01/2022 - 10/2007
5Oral ContraceptivesIBA
02/2010 - 01/2002
3AntigensIBA
03/2024 - 11/2002
3Messenger RNA (mRNA)IBA
09/2015 - 05/2007
3Complement System Proteins (Complement)IBA
03/2013 - 10/2003
2P-2 (P 2)IBA
12/2016 - 04/2013
2Diethylstilbestrol (Stilbestrol)FDA Link
04/2016 - 01/2016
2RNA (Ribonucleic Acid)IBA
09/2015 - 01/2013
2Oncogene Proteins (Oncogene Protein)IBA
09/2013 - 12/2010
2ParaffinIBA
04/2009 - 11/2007
2SmokeIBA
06/2008 - 11/2007
2CI 22IBA
10/2006 - 07/2005
2Contraceptive Agents (Contraceptives)IBA
12/2005 - 06/2005
2Peptides (Polypeptides)IBA
07/2003 - 11/2002
2GoldIBA
11/2002 - 04/2002
2Glycoproteins (Glycoprotein)IBA
07/2002 - 04/2002
1Metformin (Glucophage)FDA LinkGeneric
01/2024
1Biological FactorsIBA
01/2022
1ORALIT (ORS)IBA
01/2020
1Hemoglobins (Hemoglobin)IBA
11/2019
1Proflavine (Proflavin)IBA
11/2018
1Amino AcidsFDA Link
09/2017
1hydrogen sulfite (bisulfite)IBA
02/2015
11,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2014
1Aligeron (AS 2)IBA
07/2012
1CarcinogensIBA
01/2012
1Selective Estrogen Receptor Modulators (SERM)IBA
02/2011
1polycyclic aromatic hydrocarbons-DNA adductIBA
11/2007
1Carbon DioxideIBA
10/2007
1Nitrous Oxide (Laughing Gas)IBA
10/2007
1Therapeutic UsesIBA
10/2007
1GasesIBA
10/2007
1N 30IBA
11/2005
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2003
1telomerase RNA (bTR)IBA
10/2003
1Capsid Proteins (Capsid Protein)IBA
07/2003
1Neutralizing AntibodiesIBA
07/2003
1ImmunosorbentsIBA
07/2003
1EnzymesIBA
07/2003
1HTLV-I AntibodiesIBA
07/2003
1Ligases (Synthetase)IBA
07/2003
1AntioxidantsIBA
01/2003
1MitogensIBA
11/2002
1PhytohemagglutininsIBA
11/2002
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
11/2002
1Indicators and Reagents (Reagents)IBA
10/2002
1Heme (Haem)IBA
01/2002
1Interleukin-12 (IL 12)IBA
01/2002
1Interleukin-10 (Interleukin 10)IBA
01/2002

Therapy/Procedure

5Hysterectomy
10/2023 - 06/2005
4Secondary Prevention
01/2019 - 01/2017
3Immunotherapy
04/2024 - 02/2024
3Cryotherapy (Therapy, Cold)
07/2017 - 10/2007
2Aftercare (After-Treatment)
01/2024 - 04/2013
2Curettage
04/2013 - 11/2010
1Palliative Care (Palliative Therapy)
01/2019
1Conservative Treatment
01/2018
1Therapeutics
02/2013
1Ambulatory Care (Outpatient Care)
05/2011
1Injections
12/2005